NCT06533033View on ClinicalTrials.gov

Melatonin Epigenetic Potential in Preventing Malignant Transformation of Oral Lichen Planus

NAActive, not recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

July 31, 2024

Study Completion Date

August 1, 2024

Conditions
Oral Lichen Planus
Interventions
DRUG

Rapid Release Capsules Melatoni

"Twenty-five will be given melatonin therapy in combination with the conventional treatment.~2 tablets,30 minutes before sleeping once daily for 8 weeks."

DRUG

Triamcinolone Acetonide ointment, Kenacort-A orabase

"Twenty-five will be given topical corticosteroid applied twice to three times daily.~Topical antifungal will be applied three to four times daily. This conventional treatment will be given to the patients for 8 weeks"

Trial Locations (1)

Unknown

Outpatient Clinic of Oral medicine Department, Faculty of Dentistry, Alexandria University, Egypt, Alexandria

All Listed Sponsors
lead

Hams Hamed Abdelrahman

OTHER

NCT06533033 - Melatonin Epigenetic Potential in Preventing Malignant Transformation of Oral Lichen Planus | Biotech Hunter | Biotech Hunter